Cocrystal Pharma, Inc.

Ticker COCP

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Tucker, Georgia

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, SARS-CoV-2 virus, hepatitis C viruses, and norovirus infections. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs.

Visit website

REPORT RATINGS

4.8 / 5.0 (168)

Cocrystal Pharma, Inc. reports have an aggregate usefulness score of 4.8 based on 168 reviews.

Cocrystal Pharma, Inc.